Related Experiment Video
Updated: Apr 22, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Usability and training differences between two personal insulin pumps
Noel E Schaeffer1, Linda J Parks2, Erik T Verhoef2
1Tandem Diabetes Care, Inc, San Diego, CA, USA nschaeffer@tandemdiabetes.com.
The Tandem Diabetes Care t:slim insulin pump demonstrated significant advantages over the Medtronic MiniMed Paradigm Revel pump, requiring less training time and fewer user errors for diabetes management.
Area of Science:
- Biomedical Engineering
- Human-Computer Interaction
- Diabetes Technology
Background:
- Insulin pumps are critical for diabetes management.
- Comparing usability and training of different insulin pump models is essential for user adoption and safety.
Purpose of the Study:
- To compare the usability and training effectiveness of the Medtronic MiniMed Paradigm Revel Insulin Pump and the Tandem Diabetes Care t:slim Insulin Pump.
- To identify differences in training time, task performance, and user satisfaction between the two insulin pumps.
Main Methods:
- A between-subjects experimental design with 72 participants managing diabetes with multiple daily insulin injections.
- Participants were randomized to use either the Revel or t:slim pump in a simulated environment.
- Key metrics included training time, task completion rates, error occurrences, and System Usability Scale (SUS) scores.
Main Results:
- The t:slim pump group showed a statistically significant 27% reduction in training time compared to the Revel group.
- Participants using the t:slim pump exhibited a 65% reduction in use error rates.
- The t:slim pump demonstrated statistically significant advantages in both training and usability.
Conclusions:
- The t:slim insulin pump offers superior training efficiency and a more intuitive user experience compared to the Revel pump.
- Design elements such as optimized information architecture and active error prevention likely contribute to the t:slim's improved usability and safety.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Dosage Regimen: Individualization
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

